We are live on ! Find out more
PIC

Portland Investment Counsel Portfolio holdings

AUM $312M
1-Year Est. Return 53.32%
This Fund
S&P 500
This Quarter Est. Return
+15.23%
1 Year Est. Return
+53.32%
3 Year Est. Return
+103.89%
5 Year Est. Return
+49.43%
10 Year Est. Return
AUM
$279M
AUM Growth
+$61.8M
Cap. Flow
+$27.5M
Cap. Flow %
9.85%
Top 10 Hldgs %
75.89%
Holding
42
New
4
Increased
14
Reduced
16
Closed
3

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$22.9M
2
CVS icon
CVS Health
CVS
+$13.7M
3
DHR icon
Danaher
DHR
+$9.78M
4
MGA icon
Magna International
MGA
+$9.49M
5
BAM icon
Brookfield Asset Management
BAM
+$5.81M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$16.6M
2
FHN icon
First Horizon
FHN
+$10.3M
3
BMO icon
Bank of Montreal
BMO
+$7.2M
4
C icon
Citigroup
C
+$5.29M
5
VZ icon
Verizon
VZ
+$904K

Sector Composition

Rank Sector Weight
1 Financials 58.7%
2 Communication Services 18.64%
3 Consumer Discretionary 10.47%
4 Healthcare 10.37%
5 Technology 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTE icon
26
Baytex Energy
BTE
$3.05B
$930K 0.33%
280,300
OPTU
27
Optimum Communications Inc
OPTU
$227M
$876K 0.31%
269,679
+100,509
+59% +$263K
GS icon
28
Goldman Sachs
GS
$302B
$876K 0.31%
+2,270
New +$758K
MSFT icon
29
Microsoft
MSFT
$3.66T
$851K 0.3%
2,264
-30
-1% -$10.7K
VRN
30
DELISTED
Veren
VRN
$767K 0.27%
108,080
MA icon
31
Mastercard
MA
$490B
$586K 0.21%
1,374
-17
-1% -$6.83K
LILAK icon
32
Liberty Latin America Class C
LILAK
$1.67B
$533K 0.19%
80,097
+371
+0.5% +$2.4K
REGN icon
33
Regeneron Pharmaceuticals
REGN
$82.2B
$287K 0.1%
327
NGG icon
34
National Grid
NGG
$81.1B
$204K 0.07%
3,184
-318
-9% -$19K
SMR icon
35
NuScale Power
SMR
$3.94B
$132K 0.05%
40,000
+25,000
+167% +$88.9K
IOVA icon
36
Iovance Biotherapeutics
IOVA
$3.05B
$122K 0.04%
15,000
PLUG icon
37
Plug Power
PLUG
$3.2B
$113K 0.04%
25,000
+13,000
+108% +$68.2K
CATX icon
38
Perspective Therapeutics
CATX
$372M
$57K 0.02%
+14,255
New +$40.1K
LUMN icon
39
Lumen
LUMN
$6.49B
$26K 0.01%
14,000
-5,000
-26% -$7.09K
FHN icon
40
First Horizon
FHN
$12.3B
-931,400
Closed -$10.3M
VOD icon
41
Vodafone
VOD
$37.2B
-1,746,608
Closed -$16.6M
PNT
42
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
-20,000
Closed -$133K

Similar funds

Portland Investment Counsel's Q4 2023 Portfolio in Review

As of Q4 2023, Portland Investment Counsel held 42 positions worth $279M, up 28% from $218M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Portland Investment Counsel deployed $27.5M of net new capital in Q4 2023, opening 4 new positions and adding to 14 existing holdings. Its largest new stake was CVS Health: 191,900 shares worth $15.2M.

By sector, the portfolio is most concentrated in Financials at 59% of assets, down from 72% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Bank of Montreal, an estimated $7.2M trimmed.

  • Portland Investment Counsel's largest Q4 2023 buy was CVS Health: 191,900 shares worth $15.2M.
  • Portland Investment Counsel added most to AT&T in Q4 2023, an estimated $22.9M increase.
  • Portland Investment Counsel's biggest Q4 2023 reduction was Bank of Montreal, cutting an estimated $7.2M.
  • Portland Investment Counsel fully exited Vodafone in Q4 2023, selling an estimated $16.6M.
  • Portland Investment Counsel's ten largest holdings make up 76% of its $279M portfolio in Q4 2023.
  • Portland Investment Counsel opened 4 new positions and closed 3 in Q4 2023.
  • Portland Investment Counsel's portfolio value rose 28% quarter-over-quarter to $279M.

Based on Portland Investment Counsel's 13F filing for Q4 2023, filed 14 Feb 2024.